Pretreatment Brain Connectome Fingerprint Predicts Treatment Response in Major Depressive Disorder
Background Major depressive disorder (MDD) treatment is characterized by low remission rate and often involves weeks to months of treatment. Identification of pretreatment biomarkers of response may play a critical role in novel drug development, in enhanced prognostic predictions, and perhaps in pr...
Main Authors: | Siyan Fan, Samaneh Nemati, Teddy J. Akiki, Jeremy Roscoe, Christopher L. Averill, Samar Fouda, Lynnette A. Averill, Chadi G. Abdallah |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-12-01
|
Series: | Chronic Stress |
Online Access: | https://doi.org/10.1177/2470547020984726 |
Similar Items
-
A Unique Brain Connectome Fingerprint Predates and Predicts Response to Antidepressants
by: Samaneh Nemati, et al.
Published: (2020-01-01) -
Neurobiological studies of trauma-related psychopathology: a public health perspective
by: Teddy J. Akiki, et al.
Published: (2018-01-01) -
Ketamine, but Not the NMDAR Antagonist Lanicemine, Increases Prefrontal Global Connectivity in Depressed Patients
by: Chadi G. Abdallah, et al.
Published: (2018-08-01) -
Increased Cortical Thickness in Patients With Major Depressive Disorder Following Antidepressant Treatment
by: Samaneh Nemati, et al.
Published: (2020-01-01) -
Posttraumatic Stress Disorder and Depression Symptom Severities Are Differentially Associated With Hippocampal Subfield Volume Loss in Combat Veterans
by: Christopher L. Averill, et al.
Published: (2017-12-01)